PubRank

Hugh A G Fisher

Author PubWeight™ 14.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res 2003 2.11
2 Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence. Clin Cancer Res 2004 1.49
3 Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol 2007 1.23
4 Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol 2005 1.15
5 Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology 2006 1.12
6 Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer. Mod Pathol 2003 0.97
7 Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas. Hum Pathol 2005 0.89
8 Prognostic factors in prostate cancer. Am J Clin Pathol 2003 0.85
9 Tissue-marking scheme for a cost-effective extended prostate biopsy protocol. Urol Oncol 2008 0.84
10 Survivin and Bcl-2 expression in prostatic adenocarcinomas. Arch Pathol Lab Med 2004 0.82
11 Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer. J Urol 2003 0.80
12 Prognostic markers in prostate cancer. Expert Rev Mol Diagn 2002 0.78
13 Management of small renal cancers: choices for the patient and physician. J Urol 2006 0.77
14 Bladder cancer: in search of the right operation for the right patient. J Urol 2006 0.75
15 PSA-related markers in the detection of prostate cancer and high-grade disease in the contemporary era with extended biopsy. Urol Oncol 2007 0.75